Antinociceptive profiles and mechanisms of orally administered coumarin in mice

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 6, 2013, Pages 925-930

  Park, Soo Hyun ^a   Sim, Yun Beom ^a   Kang, Yu Jung ^a   Kim, Sung Su ^a   Kim, Chea Ha ^a   Kim, Su Jin ^a   Lim, Su Min ^a   Suh, Hong Won ^a  

^a Hallym University   (South Korea)

Author keywords

Antinociception; Coumarin; Inflammatory pain; Opioid receptor

Indexed keywords

ACETIC ACID; COUMARIN; FORMALDEHYDE; GLUTAMIC ACID; METHYSERGIDE; NALOXONE; SUBSTANCE P; YOHIMBINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; INFLAMMATORY PAIN; MALE; MOUSE; NOCICEPTION; NONHUMAN; SEROTONINERGIC SYSTEM; WRITHING TEST;

ACETIC ACID; ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; COUMARINS; FORMALDEHYDE; GLUTAMIC ACID; MALE; MICE; MICE, INBRED ICR; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; RECEPTORS, OPIOID; SUBSTANCE P;

EID: 84878837118     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00905     Document Type: Article

References (39)

1. Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov., 4, 206-220 (2005).
2. Croteau R, Kutchan TM, Lewis NG. Natural Products (Secondary Metabolites). Biochemistry and Molecular Biology of Plants. (Buchanan BB, Gruissem W, Jones RL eds.) American Society of Plant Physiologists, Rockville, p. 1308 (2000).
3. Estévez-Braun A, González AG. Coumarins. Nat. Prod. Rep., 14, 465-475 (1997).
4. Ortuno A, Botia JM, Fuster MD, Porras I, Garcia-Lidon A, del Rio JA. Effect of scoparone (6,7-dimethoxy coumarin) biosynthesis on the resistance of tangelo Nova, Citrus paradisi and Citrus aurantium fruits against Phytophthora parasitica. J. Agric. Food Chem., 45, 2740-2743 (1997).
5. Neal JJ, Wu D. Inhibition of insect cytochromes P450 by furanocoumarins. Pestic. Biochem. Physiol., 50, 43-50 (1994).
6. Gutierrez MC, Parry A, Tena M, Jorrin J, Edwards R. Abiotic elicitation of coumarin phytoalexins in sunflower. Phytochemistry, 38, 1185-1191 (1995).
7. Myers RB, Parker M, Grizzle WE. The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines. J. Cancer Res. Clin. Oncol., 120 (Suppl.), S11-S13 (1994).
8. Egan D, James P, Cooke D, Kennedy RO. Studies on the cytostatic and cytotoxic effects and mode of action of 8-nitro-7-hydroxycoumarin. Cancer Lett., 118, 201-211 (1997).
9. Adams M, Ettl S, Kunert O, Wube AA, Haslinger E, Bucar F, Bauer R. Antimycobacterial activity of gerenylated furocoumarins from Tetradium daniellii. Planta Med., 72, 1132-1135 (2006).
10. Hoult JR, Payá M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen. Pharmacol., 27, 713-722 (1996).
11. Ramesh B, Pugalendi KV. Antioxidant role of Umbelliferone in STZ-diabetic rats. Life Sci., 79, 306-310 (2006).
12. Ramesh B, Pugalendi KV. Antihyperglycemic effect of umbelliferone in streptozotocin-diabetic rats. J. Med. Food, 9, 562-566 (2006).
13. Kuete V, Metuno R, Ngameni B, Tsafack AM, Ngandeu F, Fotso GW, Bezabih M, Etoa FX, Ngadjui BT, Abegaz BM, Beng VP. Antimicrobial activity of the methanolic extracts and compounds from Treculia obovoidea (Moraceae). J. Ethnopharmacol., 112, 531-536 (2007).
14. Vasconcelos JF, Teixeira MM, Barbosa-Filho JM, Agra MF, Nunes XP, Giulietti AM, Ribeiro-Dos-Santos R, Soares MB. Effects of umbelliferone in a murine model of allergic airway inflammation. Eur. J. Pharmacol., 609, 126-131 (2009).
15. Meotti FC, Missau FC, Ferreira J, Pizzolatti MG, Mizuzaki C, Nogueira CW, Santos AR. Anti-allodynic property of flavonoid myricitrin in models of persistent inflammatory and neuropathic pain in mice. Biochem. Pharmacol., 72, 1707-1713 (2006).
16. de Lima FO, Nonato FR, Couto RD, Barbosa Filho JM, Nunes XP, Ribeiro dos Santos R, Soares MB, Villarreal CF. Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin. J. Nat. Prod., 74, 596-602 (2011).
17. Haley TJ. Pharmacological effects produced by intracerebral administration of drugs of unrelated structure to conscious mice. Arch. Int. Pharmacodyn. Ther., 110, 239-244 (1957).
18. Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol., 67, 313-316 (1980).
19. Hylden JL, Wilcox GL. Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res., 217, 212-215 (1981).
20. Choi SS, Han KJ, Lee JK, Lee HK, Han EJ, Kim DH, Suh HW. Antinociceptive mechanisms of orally administered decursinol in the mouse. Life Sci., 73, 471-478 (2003).
21. Hunskaar S, Fasmer OB, Hole K. Formalin test in mice, a useful technique for evaluating mild analgesics. J. Neurosci. Methods, 14, 69-76 (1985).
22. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain, 30, 103-114 (1987).
23. Suh HW, Song DK, Son KH, Wie MB, Lee KH, Jung KY, Do JC, Kim YH. Antinociceptive mechanisms of dipsacus saponin C administered intracerebroventricularly in the mouse. Gen. Pharmacol., 27, 1167-1172 (1996).
24. Suh HW, Song DK, Kim YH. Differential effects of adenosine receptor antagonists injected intrathecally on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the mouse. Neuropeptides, 31, 339-344 (1997).
25. Suh HW, Chung KM, Kim YH, Huh SO, Song DK. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse. Neuropeptides, 33, 121-129 (1999).
26. Choi SS, Han KJ, Lee JK, Lee HK, Han EJ, Kim DH, Suh HW. Antinociceptive mechanisms of orally administered decursinol in the mouse. Life Sci., 73, 471-485 (2003).
27. Tsuda H, Uehara N, Iwahori Y, Asamoto M, Iigo M, Nagao M, Matsumoto K, Ito M, Hirono I. Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat. Jpn. J. Cancer Res., 85, 1214-1219 (1994).
28. Vyklicky L. The techniques for the study of pain in animals. Advances in pain research and theraphy. (Bonica JJ, Liebeskind JC, Albe-Fessard DG eds.) Vol. 3, Raven, New York, pp. 727-745 (1979).
29. Satyanarayana PSV, Jain NK, Singh A, Kulkarni SK. Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice. Prog. Neuropsychopharmacol., 28, 641-649 (2004).
30. Chung KM, Lee KC, Choi SS, Suh HW. Differential roles of spinal cholera toxin- and pertussis toxin-sensitive G proteins in nociceptive responses caused by formalin, capsaicin, and substance P in mice. Brain Res. Bull., 54, 537-542 (2001).
31. Choi SS, Lee JK, Suh HW. Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models. Brain Res., 921, 233-239 (2001).
32. Puig S, Sorkin LS. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain, 64, 345-355 (1996).
33. Cumberbatch MJ, Herrero JF, Headley PM. Exposure of rat spinal neurones to NMDA, AMPA and kainate produces only short-term enhancements of responses to noxious and non-noxious stimuli. Neurosci. Lett., 181, 98-102 (1994).
34. Yaksh TL. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res., 160, 180-185 (1979).
35. Jensen TS, Yaksh TL. Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brain-stem sites. Brain Res., 321, 287-297 (1984).
36. Wigdor S, Wilcox GL. Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J. Pharmacol. Exp. Ther., 242, 90-95 (1987).
37. Schmauss C, Yaksh TL. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J. Pharmacol. Exp. Ther., 228, 1-12 (1984).
38. Yaksh TL. Multiple opioid receptor systems in brain and spinal cord: Part I. Eur. J. Anaesthesiol., 1, 171-199 (1984).
39. Yaksh TL. Opiate receptors for behavioral analgesia resemble those related to the depression of spinal nociceptive neurons. Science, 199, 1231-1233 (1978).